These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27481144)

  • 1. Inferring Chemogenomic Features from Drug-Target Interaction Networks.
    Yamanishi Y
    Mol Inform; 2013 Dec; 32(11-12):991-9. PubMed ID: 27481144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.
    Tabei Y; Pauwels E; Stoven V; Takemoto K; Yamanishi Y
    Bioinformatics; 2012 Sep; 28(18):i487-i494. PubMed ID: 22962471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparse Modeling to Analyze Drug-Target Interaction Networks.
    Yamanishi Y
    Methods Mol Biol; 2018; 1807():181-193. PubMed ID: 30030811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benchmarking a Wide Range of Chemical Descriptors for Drug-Target Interaction Prediction Using a Chemogenomic Approach.
    Sawada R; Kotera M; Yamanishi Y
    Mol Inform; 2014 Dec; 33(11-12):719-31. PubMed ID: 27485418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracting sets of chemical substructures and protein domains governing drug-target interactions.
    Yamanishi Y; Pauwels E; Saigo H; Stoven V
    J Chem Inf Model; 2011 May; 51(5):1183-94. PubMed ID: 21506615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferring protein domains associated with drug side effects based on drug-target interaction network.
    Iwata H; Mizutani S; Tabei Y; Kotera M; Goto S; Yamanishi Y
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S18. PubMed ID: 24565527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemogenomic approaches to infer drug-target interaction networks.
    Yamanishi Y
    Methods Mol Biol; 2013; 939():97-113. PubMed ID: 23192544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global optimization-based inference of chemogenomic features from drug-target interactions.
    Zu S; Chen T; Li S
    Bioinformatics; 2015 Aug; 31(15):2523-9. PubMed ID: 25819672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the accuracy of chemogenomic models with a three-dimensional binding site kernel.
    Meslamani J; Rognan D
    J Chem Inf Model; 2011 Jul; 51(7):1593-603. PubMed ID: 21644501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting target-ligand interactions using protein ligand-binding site and ligand substructures.
    Wang C; Liu J; Luo F; Deng Z; Hu QN
    BMC Syst Biol; 2015; 9 Suppl 1(Suppl 1):S2. PubMed ID: 25707321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-target interaction prediction via chemogenomic space: learning-based methods.
    Mousavian Z; Masoudi-Nejad A
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1273-87. PubMed ID: 25112457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality Issues with Public Domain Chemogenomics Data.
    Kalliokoski T; Kramer C; Vulpetti A
    Mol Inform; 2013 Dec; 32(11-12):898-905. PubMed ID: 27481136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CompoundProtein Interaction Prediction Within Chemogenomics: Theoretical Concepts, Practical Usage, and Future Directions.
    Brown JB; Niijima S; Okuno Y
    Mol Inform; 2013 Dec; 32(11-12):906-21. PubMed ID: 27481137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemogenomic Approaches for Revealing Drug Target Interactions in Drug Discovery.
    Bhargava H; Sharma A; Suravajhala P
    Curr Genomics; 2021 Dec; 22(5):328-338. PubMed ID: 35283667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical-protein interactome and its application in off-target identification.
    Yang L; Wang KJ; Wang LS; Jegga AG; Qin SY; He G; Chen J; Xiao Y; He L
    Interdiscip Sci; 2011 Mar; 3(1):22-30. PubMed ID: 21369884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Approaches to Target Fishing and Ligand Profiling.
    Rognan D
    Mol Inform; 2010 Mar; 29(3):176-87. PubMed ID: 27462761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting drug-target interaction networks of human diseases based on multiple feature information.
    Yu W; Yan Y; Liu Q; Wang J; Jiang Z
    Pharmacogenomics; 2013 Nov; 14(14):1701-7. PubMed ID: 24192119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular response to drug perturbation is limited: comparison of large-scale chemogenomic fitness signatures.
    Barazandeh M; Kriti D; Nislow C; Giaever G
    BMC Genomics; 2022 Mar; 23(1):197. PubMed ID: 35277135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
    Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
    Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Target Networks.
    Vogt I; Mestres J
    Mol Inform; 2010 Jan; 29(1-2):10-4. PubMed ID: 27463845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.